KCT0002341进行中（未招募）未知
A randomized, open-label, single dose, 3-way crossover study to evaluate the drug-drug interaction between Aceclofenac 200 mg and Esomeprazole 20 mg in healthy volunteers
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- Male
入选标准
- •1. A healthy man over 19 years old
- •2. Body Mass Index(BMI)=17.5~30.5kg/m2, one with weight of more than 55kg (BMI= kg/(m)2)
- •3. Congenital or chronic diseases within the last three years, there is no medical examination results of popular characters with no psychotic symptoms or findings
- •4. Depending on the nature of the drug your doctor check conducted hematology, blood chemistry, urinalysis and laboratory tests, including an electrocardiogram(EKG) performed during screening tests such as a suitable test subjects who judged
- •5. The purpose of the test participants prior to testing, information, and to hear about the free will fully explain to participate in this study, according to the Institutional Review Board(IRB)-approved consent form signed by the parties in writing
- •6. One who has the ability and willinigness to participate during the clinical study period.
排除标准
- •1. one with clinically significant blood, kidneys, endocrine, respiratory, gastrointestinal, urinary, cardiovascular, hepatic, psychiatric, neurological or allergic disease (but ,except for untreated seasonal allergies of asymptomatic at the time of administration) with medical history or evidence
- •2. one with gastrointestinal disease(Such as esophageal stricture or achalasia of the esophagus disease, Crohn disease) to affect drug absorption or surgery(but, excluding simple appendectomy or hernia surgery) with medical history
- •3. Alanine Aminotransferase(ALT) or Aspartate Aminotransferase(AST) > 2 times the upper limit of the normal range
- •4. Within 6 months, 210 g / week of alcohol in excess of a history of regular characters
- •5. Take part in other clinical trials within three months
- •6. Systolic Blood Pressure(SBP) = 140 mmHg or Diastolic Blood Pressure (DBP) = 90 mmHg
- •7. The great history of alcohol or drug abuse within 1 year
- •8. Taking medication of drug-metabolizing enzymes that are known to significantly induce or inhibit within 30 days
- •9. More than 20 cigarettes a day smoker
- •10. Taking medication of a prescription drug or nonprescription within 10 days,
- •11. Within two months the whole blood donation have, within one month of the apheresis donation have
- •12. Participate in clinical trials to test drug administration and may be at increased risk due to interpretation of test results, or may interfere with severe supply / chronic medical or mental condition or abnormal laboratory test values in character.
- •13. One who is not willing or able to comply with the protocol
- •14. One who is judged by the investigator to be ineligible for participation in the study.
研究者
相似试验
已完成
不适用
A clinical trial to investigate the effect of food on the pharmacokinetics of HSG4112 in healthy male volunteersKCT0005208Seoul National University Hospital12
进行中（未招募）
不适用
Clinical study to test that the drug CHF 1535 100/6 (fixed combination of an anti-inflammatory drug and relaxing airways drug) delivered via pressurized inhaler using or not a spacer device is as effective in adolescent population as the licensed free combination of the same substances and compare it with administration in adults.MedDRA version: 14.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersAsthmaEUCTR2011-005108-14-PLChiesi Farmaceutici S.p.A.
已完成
不适用
Relative bioavailability study of two candidate tablet formulations of 16mg candesartan cilexetil (GW615775) compared with the reference product Atacand (16mg candesartan cilexetil, AstraZeneca) in healthy human subjects under fasting conditionsCTRI/2014/12/005269GlaxoSmithKline Research and Development Limited18
已完成
不适用
A randomized, open-label, single dose, 2-way crossover study to evaluate the pharmacokinetic characteristics of EL-1401 in comparison to the co-administration of nebivolol and rosuvastatin in healthy volunteersDiseases of the circulatory systemKCT0002283Elyson Pharmaceutical50
已完成
不适用
A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male VolunteersEndocrine, nutritional and metabolic diseaseKCT0001757Chong Kun Dang26